A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma
Status:
Terminated
Trial end date:
2016-01-26
Target enrollment:
Participant gender:
Summary
This randomized, double-blind, placebo-controlled study will assess the efficacy and safety
of vismodegib with surgery in participants with basal cell carcinoma.